AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal

The post-marketing safety profile of Crestor is in line with the overall experience of the statin category, AstraZeneca said May 19 in response to a renewed request from Public Citizen for withdrawal of the cholesterol-lowering drug